2026
1. Challenges and Recommendations in Establishing National Human Diversity Genomic Projects. Oleksyk TK, Wolfsberger WW, Chhugani K, Huang YN, Pokrytiuk V, Shchubelka K, Zelikovsky A, Pasaniuc B, Jinga V, Bucur O, Edmunds SC, Guio H, Lombard Z, Henn BM, Lobiuc A, Levitchi A, Ciorba D, Bostan V, Munteanu V, Gordeev V, Schaaf CP, Hoh BP, Moreno Estrada A, Covasa M, Dimian M, Kairov U, Pak VM, Seow SW, Chiang CWK, Nepolo E, Pellegrini M, Hamdi Y, Abedalthagafi MS, Mulder NJ, Mooney J, Sanchez-Galan JE, de Souza SJ, Raventós H, Muzzio M, Chavarria-Soley G, Mangul S. Nature Methods 2026, in press (IF = 32.1).
2. Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases. Annapragada AV, Foda ZH, Orjuela H, Norton C, Koul S, Niknafs N, Short S, Boyapati K, Bartolomucci A, Mathios D, Noë M, Cherry C, Carey J, Leal A, Chesnick B, Dracopoli NC, Medina JE, Vulpescu NA, Bruhm DC, Bacus S, Adleff V, Kim AK, Baylin SB, Kirk GD, Sorop A, Iacob R, Iacob S, Gheorghe L, Dima S, Ramírez-Zea M, McGlynn KA, Feltoft CL, Johansen JS, Groopman J, Phallen J, Scharpf RB, Velculescu VE. Sci Transl Med. 2026 Mar 4;18(839):eadw2603. doi: 10.1126/scitranslmed.adw2603 .PMID: 41779869 (IF = 14.6).
3. Gene-sized editing for the therapy of genetic diseases. Padureanu T, Cocoș R, Matache IM, Bucur O. Funct Integr Genomics. 2026 Mar 13;26(1):63. doi: 10.1007/s10142-026-01823-1. PMID: 41820622 (IF = 3.1).
4. Mendelian randomization studies in atopic dermatitis: causal insights across omics layers. Chera A, Bucur O, Bumbăcea RS. Front Immunol. 2026 Feb 26;17:1717812. doi: 10.3389/fimmu.2026.1717812. eCollection 2026. PMID: 41836422 (IF = 5.9).
5. AI-Based Prediction of Gene Expression in Single-Cell and Multiscale Genomics and Transcriptomics. Pălăștea EA, Matache IM, Radu E, Henegariu O, Bucur O. Int J Mol Sci. 2026 Jan 13;27(2):801. doi: 10.3390/ijms27020801. PMID: 41596454 (IF = 4.9).
2025
1. The CTDP1 Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic Approaches. Sabau IM, Chera A, Ungureanu VG, Cretu Stancu M, Chirita-Emandi A, Wood M, Puiu M, Bucur O. Int J Mol Sci. 2025 Dec 19;27(1):34. doi: 10.3390/ijms27010034. PMID: 41515914 (IF = 4.9).
2. Impact of Genetic Testing Using Gene Panels, Exomes, and Genome Sequencing in Romanian Children with Epilepsy. Sabau IM, Bacos-Cosma IS, Streata I, Dragulescu B, Puiu M, Chirita-Emandi A.Int J Mol Sci. 2025 May 19;26(10):4843. doi: 10.3390/ijms26104843.PMID: 40429983 (IF = 4.9).
3. Phenotypic Variability Associated with Jagunal Homolog 1 (JAGN1) Deficiency Caused by the c.63G>T Variant. Pantea CL, Bataneant M, Zimbru CG, Serban M, Puiu M, Chirita-Emandi A.Int J Mol Sci. 2026 Feb 11;27(4):1735. doi: 10.3390/ijms27041735. PMID: 41751872 (IF = 4.9).
4. Clinical Characteristics and Prognosis of Patients with End-Stage Hypertrophic Cardiomyopathy from a Tertiary Center Cohort: Systolic Dysfunction and Advanced Diastolic Dysfunction. Afana AS, Adam RD, Militaru S, Onciul S, Andrei O, Chirita Emandi A, Puiu M, Militaru C, Jurcut R. Diagnostics (Basel). 2025 Apr 29;15(9):1134. doi: 10.3390/diagnostics15091134. PMID: 40361952 (IF = 3.3).
5. Disease-Modifying Treatment Options in Very Early Onset Multiple Sclerosis-What Choices Are There for Onset Under 5 Years of Age? A Systematic Review. Craiu D, Dica AD, Pomeran C, Pescaru G, Menascu S, Simu M. J Clin Med. 2025 Nov 17;14(22):8133. doi: 10.3390/jcm14228133.PMID: 41303170 (IF = 2.8).
6. Brain Matters in Duchenne Muscular Dystrophy: DMD Mutation Sites and Their Association with Neurological Comorbidities Through Isoform Impairment. Barbarii T, Tudorache RA, Craiu D, Neagu E, Brinduse LA, Burloiu CM, Iliescu CM, Budisteanu M, Minciu I, Barca DG, Sandu C, Tarta-Arsene O, Pomeran C, Motoescu C, Dica A, Anghelescu C, Surlica D, Toma AI, Butoianu N. Genes (Basel). 2025 Dec 24;17(1):12. doi: 10.3390/genes17010012.PMID: 41595432 (IF = 2.8).
2024
1. Metformin drugs under simulated gastric conditions can generate high nitrite-dependent levels of N-nitrosodimethylamine. Georgescu GC, Cretu-Stancu M, Bucur O. Sci Rep. 2024 Jun 17;14(1):13910. doi: 10.1038/s41598-024-63032-9.PMID: 38886399 (IF = 3.9).
2. Shedding light on DNA methylation and its clinical implications: the impact of long-read-based nanopore technology. Chera A, Stancu-Cretu M, Zabet NR, Bucur O. Epigenetics Chromatin. 2024 Dec 30;17(1):39. doi: 10.1186/s13072-024-00558-2.PMID: 39734197 (IF = 3.5).
3. Scrutinizing neurodegenerative diseases: decoding the complex genetic architectures through a multi-omics lens. Cocoș R, Popescu BO. Hum Genomics. 2024 Dec 31;18(1):141. doi: 10.1186/s40246-024-00704-7. PMID: 39736681 (IF = 4.3).
4. Space Travel: The Radiation and Microgravity Effects on the Cardiovascular System. Mircea AA, Pistritu DV, Fortner A, Tanca A, Liehn EA, Bucur O. Int J Mol Sci. 2024 Nov 3;25(21):11812. doi: 10.3390/ijms252111812. PMID: 39519362 (IF = 4.9).
5. Oncolytic Viruses as Reliable Adjuvants in CAR-T Cell Therapy for Solid Tumors. Stilpeanu RI, Secara BS, Cretu-Stancu M, Bucur O. Int J Mol Sci. 2024 Oct 16;25(20):11127. doi: 10.3390/ijms252011127.PMID: 39456909 (IF = 4.9).
6. Multiplexed spatial transcriptomics methods and the application of expansion microscopy. Fortner A, Bucur O. Front Cell Dev Biol. 2024 Jul 22;12:1378875. doi: 10.3389/fcell.2024.1378875. eCollection 2024. PMID: 39105173 (IF = 4.3).